Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Opus Genetics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −6 vs. Q2 2021
- Shares held
- 1.68M
- +611.0K (+57.2%) vs. Q2 2021
- Total value
- $8.62M
- +$3.02M (+53.8%) vs. Q2 2021
- New holders
- 6
- 9 more added
- Sold out
- 12
- 6 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 103 | $236.4M |
| Q1 2026 | 79 | $203.8M |
| Q4 2025 | 59 | $55.9M |
| Q3 2025 | 48 | $31.9M |
| Q2 2025 | 43 | $16.5M |
| Q1 2025 | 46 | $14.7M |
| Q4 2024 | 43 | $4.38M |
| Q3 2024 | 38 | $3.32M |
| Q2 2024 | 37 | $4.13M |
| Q1 2024 | 49 | $6.78M |
| Q4 2023 | 50 | $11.2M |
| Q3 2023 | 50 | $12.6M |
| Q2 2023 | 49 | $16.0M |
| Q1 2023 | 41 | $13.0M |
| Q4 2022 | 35 | $10.9M |
| Q3 2022 | 37 | $5.69M |
| Q2 2022 | 38 | $4.62M |
| Q1 2022 | 41 | $6.69M |
| Q4 2021 | 40 | $8.07M |
| Q3 2021 | 30 | $8.62M |
| Q2 2021 | 36 | $5.61M |
| Q1 2021 | 27 | $5.27M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Opus Genetics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 980,737 | $5.05M | 0.00% | +943,591+2,540.2% | Added |
| Ikarian Capital, LLC | 118,063 | $608.0K | 0.14% | −1,488−1.2% | Reduced |
| Geode Capital Management, LLC | 78,923 | $406.0K | 0.00% | +53,329+208.4% | Added |
| Citadel Advisors LLC | 57,502 | $296.0K | 0.00% | +43,245+303.3% | Added |
| Two Sigma Advisers, LP | 43,900 | $226.0K | 0.00% | +43,900 | New |
| Susquehanna International Group, LLP | 40,794 | $210.0K | 0.00% | −18,378−31.1% | Reduced |
| Two Sigma Investments, LP | 36,883 | $190.0K | 0.00% | +36,883 | New |
| BlackRock Inc. | 33,913 | $175.0K | 0.00% | −514−1.5% | Reduced |
| Group One Trading, L.P. | 31,633 | $163.0K | 0.00% | +11,656+58.3% | Added |
| Millennium Management LLC | 26,427 | $136.0K | 0.00% | +26,427 | New |
| Frontier Wealth Management LLC | 25,000 | $129.0K | 0.01% | +25,000 | New |
| Comerica Bank | 30,000 | $127.0K | 0.00% | 00.0% | Unchanged |
| Occudo Quantitative Strategies LP | 21,719 | $112.0K | 0.01% | −1,726−7.4% | Reduced |
| LPL Financial LLC | 20,024 | $103.0K | 0.00% | +20,024 | New |
| Morgan Stanley | 19,160 | $99.0K | 0.00% | +5,500+40.3% | Added |
| Susquehanna Fundamental Investments, LLC | 19,041 | $98.0K | 0.00% | +2,600+15.8% | Added |
| State Street Corp | 14,973 | $77.0K | 0.00% | −39,600−72.6% | Reduced |
| Regency Capital Management Inc. | 15,000 | $77.0K | 0.05% | 00.0% | Unchanged |
| Stokes Family Office, LLC | 12,120 | $62.0K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 12,131 | $62.0K | 0.00% | +12,131 | New |
| Boothbay Fund Management, LLC | 11,901 | $61.0K | 0.00% | −1,488−11.1% | Reduced |
| Cornerstone Capital, Inc. | 11,357 | $58.0K | 0.01% | 00.0% | Unchanged |
| MCF Advisors LLC | 9,499 | $49.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 7,838 | $41.0K | 0.00% | +2,296+41.4% | Added |
| First Manhattan Co | 600 | $3.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 421 | $2.00K | 0.00% | +400+1,904.8% | Added |
| Wells Fargo & Company | 67 | $0 | 0.00% | +63+1,575.0% | Added |
| Royal Bank of Canada | 5 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 2 | $0 | 0.00% | 00.0% | Unchanged |
| NEXT Financial Group, Inc | 41 | $0 | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −329,131−100.0% | Sold out |
| Norris Perne & French LLP | 0 | $0 | 0.00% | −78,909−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −37,315−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −35,529−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −24,984−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −19,395−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −14,900−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −7,900−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,312−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| Salem Investment Counselors Inc | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Close Asset Management Ltd | 0 | $0 | 0.00% | −20−100.0% | Sold out |